METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES
摘要
Tumors are identified as responsive to treatment with anti-HER2 antibodies by detecting the presence of a HER2/HER3 and/or HER2/HER1 protein complex or for HER2 phosphorylation in a sample of tumor cells. Patients suffering from a tumor comprising HER/2/HER1 and/or HER2/HER3 heterodimers and/or HER2 phosphorylation are treated with anti-HER2 antibodies, such as rhuMAb 2C4.
申请公布号
WO2004008099(A8)
申请公布日期
2005.02.17
申请号
WO2003US21590
申请日期
2003.07.11
申请人
GENENTECH, INC.;F. HOFFMANN - LA ROCHE AG;KOLL, HANS;BOSSENMAIER, BIRGIT;MUELLER, HANS-JOACHIM;SLIWKOWSKI, MARK, X.;KELSEY, STEPHEN, MICHAEL
发明人
KOLL, HANS;BOSSENMAIER, BIRGIT;MUELLER, HANS-JOACHIM;SLIWKOWSKI, MARK, X.;KELSEY, STEPHEN, MICHAEL